Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD
Eva Katharina Messer, Janett Fischer, Toni Herta, Albrecht Boehlig, Madlen Matz-Soja, Adrienn Tuennemann-Tarr, Susanne Gaul, Ulrich Laufs · 2026
Read Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD by Eva Katharina Messer, Janett Fischer, Toni Herta, Albrecht Boehlig, Madlen Matz-Soja, Adrienn Tuennemann-Tarr, Susanne Gaul, Ulrich Laufs (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0349666.txt.
Description
Eva Messer and colleagues tracked a fat-regulating blood protein, ApoC3, across the stages of the common fatty liver disease now called MASLD. The protein helps govern triglycerides and is tied to heart risk, but its behavior as liver disease advances was unclear. Blood from a hundred ninety-seven patients, from simple fatty liver through scarring to liver cancer, was compared with samples from healthy donors.
ApoC3 did not simply climb with damage. It ran lower in the cirrhosis and cancer stages than in early disease or in controls, and low values traveled with other signs of advanced liver failure. That arc matters for drug developers, since new medicines aim to block this very protein: the stage of disease may decide whether lowering it further helps, harms, or misses the point entirely.
Catalog record
| CREATOR | Eva Katharina Messer, Janett Fischer, Toni Herta, Albrecht Boehlig, Madlen Matz-Soja, Adrienn Tuennemann-Tarr, Susanne Gaul, Ulrich Laufs |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34251 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |